Abstract
The mitochondrial deoxyribonucleotide (dNTP) pool is separated from the cytosolic pool because the mitochondria inner membrane is impermeable to charged molecules. The mitochondrial pool is maintained by either import of cytosolic dNTPs through dedicated transporters1,2 or by salvaging deoxynucleosides within the mitochondria; apparently, enzymes of the de novo dNTP synthesis pathway are not present in the mitochondria. In non-replicating cells, where cytosolic dNTP synthesis is down-regulated, mtDNA synthesis depends solely on the mitochondrial salvage pathway enzymes, the deoxyribonucleosides kinases. Two of the four human deoxyribonucleoside kinases, deoxyguanosine kinase (dGK) and thymidine kinase-2 (TK2), are expressed in mitochondria3,4,5,6. Human dGK efficiently phosphorylates deoxyguanosine and deoxyadenosine, whereas TK2 phosphorylates deoxythymidine, deoxycytidine and deoxyuridine. Here we identify two mutations in TK2, histidine 90 to asparagine and isoleucine 181 to asparagine, in four individuals who developed devastating myopathy and depletion of muscular mitochondrial DNA in infancy. In these individuals, the activity of TK2 in muscle mitochondria is reduced to 14–45% of the mean value in healthy control individuals. Mutations in TK2 represent a new etiology for mitochondrial DNA depletion, underscoring the importance of the mitochondrial dNTP pool in the pathogenesis of mitochondrial depletion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bridges, E.G., Jiang, Z. & Cheng, Y.C. Characterization of a dCTP transport activity reconstituted from human mitochondria. J. Biol. Chem. 274, 4620–4625 (1999).
Dolce, V.V., Fiermonte, G., Runswick, M.J., Palmieri, F. & Walker, J.E. The human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antivirals. Proc. Natl Acad. Sci. USA 98, 2284–2288 (2001).
Wang, L., Hellman, U. & Eriksson, S. Cloning and expression of human mitochondrial deoxyguanosine kinase cDNA. FEBS Lett. 390, 39–43 (1996).
Johansson, M. & Karlsson, A. Cloning and expression of human deoxyguanosine kinase cDNA. Proc. Natl Acad. Sci. USA 93, 7258–7262 (1996).
Johansson, M. & Karlsson, A. Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2. J. Biol. Chem. 272, 8454–8458 (1997).
Wang, L. et al. Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates. FEBS Lett. 443, 170–174 (1999).
Ducluzeau, P.H. et al. Depletion of mitochondrial DNA associated with infantile cholestasis and progressive liver fibrosis. J. Hepat. 30, 149–155 (1999).
Blake, J.C. et al. Mitochondrial DNA depletion syndrome is expressed in amniotic fluid cell cultures. Am. J. Path. 155, 67–70 (1999).
Tritschler, H.J. et al. Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology 42, 209–217 (1992).
Vu, T.H. et al. Clinical manifestations of mitochondrial DNA depletion. Neurology 50, 1783–1790 (1998).
Taanman, J.W. et al. Molecular mechanisms in mitochondrial DNA depletion syndrome. Hum. Mol. Genet. 6, 935–942 (1997).
Moraes, C.T. et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am. J. Hum. Genet. 48, 492–501 (1991).
Bodnar, A.G., Cooper, J.M., Holt, I.J., Leonard, J.V. & Schapira, A.H.V. Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion. Am. J. Hum. Genet. 53, 663–669 (1993).
Mariotti, C. et al. Early-onset encephalomyopathy associated with tissue-specific mitochondrial DNA depletion: a morphological, biochemical and molecular-genetic study. J. Neurol. 242, 547–556 (1995).
Spelbrink, J.N. et al. Familial mitochondrial DNA depletion in liver: haplotype analysis of candidate genes. Hum. Genet. 102, 327–331 (1998).
Moraes, C.T. What regulates mitochondrial DNA copy number in animal cells? Trends Genet. 17, 199–205 (2001).
Nishino, I., Spinazzola, A. & Hirano, M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283, 689–692 (1999).
Lewis, W. & Dalakas, M.C. Mitochondrial toxicity of antiviral drugs. Nature Med. 1, 417–422 (1995).
Mandel, H. et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nature Genet. 29, 337–341 (2001).
Rampazzo, C. et al. deoxyribonucleotidase in mitochondria: involvement in regulation of dNTP pools and possible link to genetic disease. Proc. Natl Acad. Sci. USA 97, 8239–8244 (2000).
Hoppel, C. & Cooper, C. An improved procedure for preparation of inner membrane vesicles from rat liver mitochondria by treatment with digitonin. Arch. Biochem. Biophys. 135, 173–183 (1969).
Dooijewaard, G. & Slater, E.C. Steady state kinetics of high molecular weight (type I) NADH dehydrogenase. Biochem. Biophys. Acta 440, 1–15 (1976).
Fischer, J.C. et al. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin. Chim. Acta 153, 23–36 (1985).
Cooperstein, S.J. & Lazarow, A. A microspectrophotometric method for the determination of cytochrome oxidase. J. Biol. Chem. 189, 665–670 (1951).
Barth, P.G. et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J. Neurol. Sci. 62, 327–355 (1983).
Rustin, P. et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 228, 35–51 (1994).
Newton, C.R. et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 17, 2503–2516 (1989).
Wang, L. & Eriksson, S. Cloning and characterization of full-length mouse thymidine kinase 2: the N-terminal sequence directs import of the precursor protein into mitochondria. Biochem. J. 351, 469–176 (2000).
Acknowledgements
We thank Dr. E. Levy-Lahad for helpful discussion and C. Belaiche for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
Saada, A., Shaag, A., Mandel, H. et al. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29, 342–344 (2001). https://doi.org/10.1038/ng751
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng751
This article is cited by
-
Differential expression of enzymes in thymidylate biosynthesis in zebrafish at different developmental stages: implications for dtymk mutation-caused neurodegenerative disorders
BMC Neuroscience (2022)
-
Artificial neural network applied to fragile X-associated tremor/ataxia syndrome stage diagnosis based on peripheral mitochondrial bioenergetics and brain imaging outcomes
Scientific Reports (2022)
-
Thymidine Kinase 2 and Mitochondrial Protein COX I in the Cerebellum of Patients with Spinocerebellar Ataxia Type 31 Caused by Penta-nucleotide Repeats (TTCCA)n
The Cerebellum (2022)
-
Muscle MRI characteristic pattern for late-onset TK2 deficiency diagnosis
Journal of Neurology (2022)
-
Collaborative model for diagnosis and treatment of very rare diseases: experience in Spain with thymidine kinase 2 deficiency
Orphanet Journal of Rare Diseases (2021)
